Trials / Recruiting
RecruitingNCT05783505
A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use
PRevention of pAtient's agItation and Enhancement of Their SafEty (PRAISE): Improving Intensive Care Treatment Using a Multicomponent Pharmacological Intervention
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 480 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite deleterious effects, physical restraints are still commonly used in (expected to become) agitated patients in Dutch ICUs (20-25%). This study aims to determine the effectiveness of a person-centered multicomponent intervention (MCI) program consisting of non-pharmacological interventions combined with goal directed light sedation using dexmedetomidine compared to the old standard of care including physical restraints in (expected to become) agitated adult ICU patients.
Detailed description
Applying physical restraints (PR) has detrimental short- and long-term effects on patients and is increasingly seen as inhumane and outdated. Nonetheless, PR are still used in approximately 20-25% of all patients during their intensive care unit (ICU) stay in the Netherlands. The aim of this study is to determine the effectiveness of a person-centered multicomponent intervention (MCI) program consisting of non-pharmacological interventions combined with goal directed light sedation using dexmedetomidine compared to the old standard of care including physical restraints on short- and long-term outcomes and healthcare costs in (expected to become) agitated adult ICU patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Multicomponent intervention program | Non-pharmacological interventions combined with goal directed sedation using dexmedetomidine if needed |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-10-01
- Completion
- 2026-10-01
- First posted
- 2023-03-24
- Last updated
- 2025-06-17
Locations
5 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05783505. Inclusion in this directory is not an endorsement.